SYK News and Press, Stryker Corporation

2026-03-11 11:16:49 ET More on Stryker Stryker Corporation (SYK) Q4 2025 Earnings Call Transcript Stryker's ASC Advantage Is Real But Largely Priced In Despite Reassurances On Growth, The Market Hasn't Warmed To Stryker Stryker projects 8%–9.5% organic...

Stryker launches SmartHospital Platform PR Newswire New platform connects devices, data and care teams across the patient journey to streamline operations and enhance outcomes for patients and staff PORTAGE, Mich. , March 9, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a glob...

2026-03-05 12:15:07 ET William Blair analyst issues OUTPERFORM recommendation for SYK on March 5, 2026 02:34PM ET. The previous analyst recommendation was Outperform. SYK was trading at $371.76999 at issue of the analyst recommendation. The overall analyst consensus : BU...

2026-03-04 19:03:33 ET Matthew Taylor from Jefferies issued a price target of $465.00 for SYK on 2026-03-04 22:00:00. The adjusted price target was set to $465.00. At the time of the announcement, SYK was trading at $381.89. The overall price target consensus is at $424....

2026-03-04 13:02:06 ET This article is part of a series that provides an ongoing analysis of the changes made to Fundsmith’s 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 02/17/2026. Please visit our Tracking Terry Smith’s Fund...

2026-03-03 10:36:00 ET ... Read the full article on Seeking Alpha For further details see: Baron Health Care Fund Q4 2025 Recent Activity

2026-03-03 10:18:00 ET ... Read the full article on Seeking Alpha For further details see: Baron Health Care Fund Q4 2025 Contributors And Detractors

Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting PR Newswire Evolving technologies and offerings reinforce commitment to shaping the future of orthopaedic care PORTAGE, Mich. , March 3, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a glo...

2026-02-27 15:01:26 ET I last covered LeMaitre Vascular (NASDAQ:LMAT) at $81 in June 2025 , reiterating my Buy rating. Eight months later, shares are up about 35%, more than double that of the broader market. The stock jumped ~20% alone on the recent Q4 beat and raise, with 2026 guidanc...

Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation PR Newswire Elevating care with Stryker's next generation device, Synchfix EVT , which will be featured at the 2026 American College of Foot and Ankle Surgeons (ACFAS) Annual Meeting PORTAG...